Sector Gamma As as of June 30, 2022
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 37 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 11.7 | $52M | 843k | 61.81 | |
| Merck & Co (MRK) | 8.5 | $38M | 414k | 91.17 | |
| Incyte Corporation (INCY) | 7.8 | $35M | 459k | 75.97 | |
| Medtronic SHS (MDT) | 5.8 | $26M | 291k | 89.75 | |
| Bristol Myers Squibb (BMY) | 5.4 | $24M | 312k | 77.00 | |
| Cardinal Health (CAH) | 4.5 | $20M | 386k | 52.27 | |
| Boston Scientific Corporation (BSX) | 4.4 | $20M | 533k | 37.27 | |
| Biogen Idec (BIIB) | 4.2 | $19M | 93k | 203.94 | |
| Cigna Corp (CI) | 3.9 | $18M | 66k | 263.52 | |
| Anthem (ELV) | 3.7 | $17M | 34k | 482.57 | |
| Bruker Corporation (BRKR) | 3.5 | $16M | 251k | 62.76 | |
| CVS Caremark Corporation (CVS) | 3.5 | $16M | 168k | 92.66 | |
| Centene Corporation (CNC) | 3.4 | $15M | 182k | 84.61 | |
| Zimmer Holdings (ZBH) | 3.2 | $14M | 136k | 105.06 | |
| NuVasive | 2.7 | $12M | 248k | 49.16 | |
| Organon & Co Common Stock (OGN) | 2.7 | $12M | 356k | 33.75 | |
| Qiagen Nv Shs New | 2.1 | $9.5M | 202k | 47.20 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $9.4M | 34k | 281.80 | |
| Seagen | 2.0 | $9.0M | 51k | 176.95 | |
| BioMarin Pharmaceutical (BMRN) | 2.0 | $8.7M | 105k | 82.87 | |
| Alnylam Pharmaceuticals (ALNY) | 1.4 | $6.2M | 43k | 145.85 | |
| Ionis Pharmaceuticals (IONS) | 1.4 | $6.1M | 165k | 37.02 | |
| Bio Rad Labs Cl A (BIO) | 1.3 | $5.8M | 12k | 495.04 | |
| Abbott Laboratories (ABT) | 1.2 | $5.3M | 49k | 108.65 | |
| Pfizer (PFE) | 1.2 | $5.2M | 100k | 52.43 | |
| Intra Cellular Therapies (ITCI) | 1.0 | $4.6M | 81k | 57.09 | |
| Sage Therapeutics (SAGE) | 0.9 | $3.8M | 119k | 32.30 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $3.4M | 85k | 40.06 | |
| Novavax Com New (NVAX) | 0.6 | $2.8M | 55k | 51.42 | |
| Vir Biotechnology (VIR) | 0.6 | $2.8M | 110k | 25.47 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $2.8M | 46k | 59.67 | |
| Universal Hlth Svcs CL B (UHS) | 0.6 | $2.7M | 27k | 100.71 | |
| Rigel Pharmaceuticals Com New | 0.4 | $1.7M | 1.5M | 1.13 | |
| Quanterix Ord (QTRX) | 0.3 | $1.4M | 89k | 16.19 | |
| Somalogic Class A Com | 0.3 | $1.4M | 301k | 4.52 | |
| Atara Biotherapeutics | 0.2 | $964k | 124k | 7.79 | |
| Embecta Corp Common Stock (EMBC) | 0.0 | $133k | 5.2k | 25.35 |
